PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sodium dihydrogenorthophosphate | 231-449-2 | 7558-80-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium diisobutylnaphthalenesulphonate | 248-326-4 | 27213-90-7 | - | - | 2 | - | - | - | - | - | - | Details |
| sodium dithionite | 231-890-0 | 7775-14-6 | 1 | - | 2 | - | - | - | - | - | - | Details |
| Sodium hexahydroxoantimonate | 251-735-0 | 33908-66-6 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium hydrogen N-(1-oxododecyl)-L-glutamate | 249-958-3 | 29923-31-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium hydrogen N-(1-oxotetradecyl)-L-glutamate | 253-981-4 | 38517-37-2 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium hydrogen-5-sulphoisophthalate | 228-845-2 | 6362-79-4 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium iodide | 231-679-3 | 7681-82-5 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium p-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzenesulphonate | 223-989-2 | 4156-21-2 | - | - | 2 | - | - | - | - | - | - | Details |
| Sodium salts of [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid (1-3 Na:1) | 701-215-9 | - | - | - | 2 | - | - | - | - | - | - | Details |